Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911177 · ClinicalTrials.gov registry record · NA
Yeast Mannans and Stool Frequency
A NA study of Defecation Frequency, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06911177 is a NA study of Defecation Frequency that is actively recruiting participants, run by University of Florida. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06911177, a NA study of Defecation Frequency, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Findings from an open-label pilot study of 20 adults suggested that supplementation with 15 g/day of yeast mannans was highly tolerable and demonstrated specific modulation of the microbiota and increased stool frequency in a subset of subjects reporting ≤1 stool per day at baseline. The primary aim of this randomized, double-blind, controlled trial is to determine if yeast mannan supplementation at 12 g/day will increase stool frequency in generally healthy adults reporting ≤1 stool per day. Secondary aims will determine the effect of yeast mannans on intestinal transit time, gastrointestinal symptoms, fecal microbiota composition, and urinary and fecal metabolomics.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Yeast mannan
- DIETARY_SUPPLEMENT Control (placebo)
Study Locations (1)
Florida
- Department of Food Science and Human Nutrition - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-07-17 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06911177
The ClinicalTrials.gov registry entry for NCT06911177 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Defecation Frequency appearing as the primary indexed condition, and to 2 interventions - of which Yeast mannan is the first listed.
NCT06911177 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06911177 about?
NCT06911177 is a clinical study titled "Yeast Mannans and Stool Frequency". Findings from an open-label pilot study of 20 adults suggested that supplementation with 15 g/day of yeast mannans was highly tolerable and demonstrated specific modulation of the microbiota and increased stool frequency in a subset of subjects reporting ≤1 stool per day at baseline. The primary aim...
What is the current status of trial NCT06911177?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-07-17. Estimated completion is 2026-06-30.
What conditions does trial NCT06911177 study?
This clinical trial studies the following conditions: Defecation Frequency.
What interventions are being tested in trial NCT06911177?
The interventions under investigation include: Yeast mannan (DIETARY_SUPPLEMENT), Control (placebo) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06911177?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06911177 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.